These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 6200034

  • 1. Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y, Hurwitz E, Kashi R, Sela M, Hibi N, Hara A, Hirai H.
    Ann N Y Acad Sci; 1983; 417():262-9. PubMed ID: 6200034
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.
    Tsukada Y, Hurwitz E, Kashi R, Sela M, Hibi N, Hara A, Hirai H.
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7896-9. PubMed ID: 6185954
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
    Tsukada Y, Ohkawa K, Hibi N.
    Cancer Res; 1987 Aug 15; 47(16):4293-5. PubMed ID: 2440563
    [Abstract] [Full Text] [Related]

  • 4. Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y, Bischof WK, Hibi N, Hirai H, Hurwitz E, Sela M.
    Proc Natl Acad Sci U S A; 1982 Jan 15; 79(2):621-5. PubMed ID: 6176999
    [Abstract] [Full Text] [Related]

  • 5. A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate.
    Kato Y, Umemoto N, Kayama Y, Fukushima H, Takeda Y, Hara T, Tsukada Y.
    J Med Chem; 1984 Dec 15; 27(12):1602-7. PubMed ID: 6209394
    [Abstract] [Full Text] [Related]

  • 6. An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.
    Tsukada Y, Kato Y, Umemoto N, Takeda Y, Hara T, Hirai H.
    J Natl Cancer Inst; 1984 Sep 15; 73(3):721-9. PubMed ID: 6206272
    [Abstract] [Full Text] [Related]

  • 7. [Anti cancer effect of antibiotic-AFP-purified antibody conjugates].
    Tsukada Y, Hibi N, Ohkawa K, Uchino J, Hirai H.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2653-8. PubMed ID: 6210058
    [Abstract] [Full Text] [Related]

  • 8. [Chemical modification of anti-cancer drugs to increase their affinity to tumor antigens].
    Tsukada Y.
    Gan To Kagaku Ryoho; 1985 Mar 15; 12(3 Pt 2):741-50. PubMed ID: 2580485
    [Abstract] [Full Text] [Related]

  • 9. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
    Masuda K, Takahashi K, Nagata S, Hirano K, Takagishi Y.
    J Drug Target; 1994 Mar 15; 2(4):323-31. PubMed ID: 7532086
    [Abstract] [Full Text] [Related]

  • 10. Coupling daunorubicin to monoclonal antialphafoetoprotein with a new activated derivative.
    Thibeault D, Pagé M.
    Int J Immunopharmacol; 1990 Mar 15; 12(5):503-7. PubMed ID: 1698734
    [Abstract] [Full Text] [Related]

  • 11. Enhanced antitumor activity of mitomycin C conjugated with anti-alpha-fetoprotein antibody by a novel method of conjugation.
    Kato Y, Tsukada Y, Hara T, Hirai H.
    J Appl Biochem; 1983 Mar 15; 5(4-5):313-9. PubMed ID: 6207159
    [Abstract] [Full Text] [Related]

  • 12. Daunomycin-arachidonic acid complex as a potential new antitumor agent.
    Sasaki T, Tsukada Y, Deutsch HF, Hirai H.
    Cancer Chemother Pharmacol; 1984 Mar 15; 13(2):75-7. PubMed ID: 6205782
    [Abstract] [Full Text] [Related]

  • 13. Overcoming effect of antibody against rat alpha-fetoprotein (AFP) on the growth of daunorubicin-resistant mutant rat ascites hepatoma cell line AH66.
    Ohkawa K, Tsukada Y, Abe T, Takada K, Hibi N.
    Int J Cancer; 1989 Sep 15; 44(3):489-93. PubMed ID: 2476405
    [Abstract] [Full Text] [Related]

  • 14. Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents.
    Hata Y, Takada N, Sasaki F, Abe T, Hamada H, Takahashi H, Uchino J, Tsukada Y.
    J Pediatr Surg; 1992 Jun 15; 27(6):724-7. PubMed ID: 1380075
    [Abstract] [Full Text] [Related]

  • 15. [Application of anti-AFP monoclonal antibodies to diagnosis].
    Nishi S.
    Gan To Kagaku Ryoho; 1983 Feb 15; 10(2 Pt 2):631-5. PubMed ID: 6192764
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.
    Belles-Isles M, Pagé M.
    Br J Cancer; 1980 May 15; 41(5):841-2. PubMed ID: 6158968
    [No Abstract] [Full Text] [Related]

  • 17. Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture.
    Tsukazaki K, Hayman EG, Ruoslahti E.
    Cancer Res; 1985 Apr 15; 45(4):1834-8. PubMed ID: 2579736
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum alpha-fetoprotein level of nude mice bearing hepatoma cells by treatment with monoclonal antibodies to alpha-fetoprotein.
    Masuda K, Nagata S, Hirano K, Takagishi Y, Hirai H.
    Biochim Biophys Acta; 1993 Sep 08; 1182(2):128-32. PubMed ID: 7689341
    [Abstract] [Full Text] [Related]

  • 19. The inhibitory effects of horse anti-rat AFP antiserum on the uptake of 2-deoxy-D-glucose by AFP-producing rat hepatoma cells.
    Ohkawa K, Tsukada Y, Hibi N, Hirai H.
    Int J Cancer; 1984 Apr 15; 33(4):497-502. PubMed ID: 6200448
    [Abstract] [Full Text] [Related]

  • 20. [Preparation of conjugates of adriamycin with antibodies to alpha-fetoprotein and their properties].
    Nishiwaki S, Takei N, Higashi T, Hibi N, Tsukada Y, Hirai H.
    Gan To Kagaku Ryoho; 1984 Aug 15; 11(8):1591-7. PubMed ID: 6206799
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.